Literature DB >> 19728191

Biological characteristics of carbon-ion therapy.

Koichi Ando1, Yuki Kase.   

Abstract

PURPOSE: Radiotherapy using charged and/or high-linear energy transfer (LET) particles has a long history, starting with proton beams up to now carbon-ions. Radiation quality of particle beams is different from conventional photons, and therefore the biological effects of high-LET irradiation have attracted scientific interests of many scientists in basic and clinical fields. A brief history of particle radiotherapy in the past half-century is followed by the reviewed biological effectiveness of high-LET charged particles.
RESULTS: The latter includes 54 papers presenting 506 RBE (relative biological effectiveness) values for carbon ions and a total of 290 RBE values for other ions identified from 48 papers. By setting a selection window of LET up to 100 keV/microm, we fitted a linear regression line to an LET-RBE relation. The resulting slope of the regression line had a dimension of microm/keV, and showed different steepness for different cells/tissues and endpoints as well. The steepest regression was found for chromosome aberration of human malignant melanoma while the shallowest was for apoptosis of rodent cells/tissue. Both tumour and normal tissue showed relatively shallower slopes than colony formation.
CONCLUSIONS: In general, there is a large variation of slope values, but the majority (25 out of 29 values) of data was smaller than 0.05 microm/keV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728191     DOI: 10.1080/09553000903072470

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  38 in total

Review 1.  Charged-particle therapy for hepatocellular carcinoma.

Authors:  Heath D Skinner; Theodore S Hong; Sunil Krishnan
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  Long-term consequences of radiation-induced bystander effects depend on radiation quality and dose and correlate with oxidative stress.

Authors:  Manuela Buonanno; Sonia M de Toledo; Debkumar Pain; Edouard I Azzam
Journal:  Radiat Res       Date:  2011-02-14       Impact factor: 2.841

Review 3.  Proton RBE dependence on dose in the setting of hypofractionation.

Authors:  Thomas Friedrich
Journal:  Br J Radiol       Date:  2019-08-28       Impact factor: 3.039

4.  Evolution of Care of Orbital Tumors with Radiation Therapy.

Authors:  Myrsini Ioakeim-Ioannidou; Shannon M MacDonald
Journal:  J Neurol Surg B Skull Base       Date:  2020-08-24

5.  Estimation of linear energy transfer distribution for broad-beam carbon-ion radiotherapy at the National Institute of Radiological Sciences, Japan.

Authors:  Nobuyuki Kanematsu; Naruhiro Matsufuji; Taku Inaniwa
Journal:  Radiol Phys Technol       Date:  2018-02-22

Review 6.  Expanding the therapeutic index of radiation therapy by normal tissue protection.

Authors:  Pierre Montay-Gruel; Lydia Meziani; Chakradhar Yakkala; Marie-Catherine Vozenin
Journal:  Br J Radiol       Date:  2018-07-02       Impact factor: 3.039

7.  The differential role of human macrophage in triggering secondary bystander effects after either gamma-ray or carbon beam irradiation.

Authors:  Chen Dong; Mingyuan He; Wenzhi Tu; Teruaki Konishi; Weili Liu; Yuexia Xie; Bingrong Dang; Wenjian Li; Yukio Uchihori; Tom K Hei; Chunlin Shao
Journal:  Cancer Lett       Date:  2015-04-17       Impact factor: 8.679

Review 8.  Role of High-Linear Energy Transfer Radiobiology in Space Radiation Exposure Risks.

Authors:  Akihisa Takahashi; Hiroko Ikeda; Yukari Yoshida
Journal:  Int J Part Ther       Date:  2018-09-21

9.  Maximum standardized uptake value on FDG-PET predicts survival in stage I non-small cell lung cancer following carbon ion radiotherapy.

Authors:  Katsuyuki Shirai; Takanori Abe; Jun-Ichi Saitoh; Tatsuji Mizukami; Daisuke Irie; Yosuke Takakusagi; Shintaro Shiba; Naoko Okano; Takeshi Ebara; Tatsuya Ohno; Takashi Nakano
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

10.  Hypofractionation in prostate cancer radiotherapy: a step forward towards clinical routine.

Authors:  Barbara Vischioni; Rachele Petrucci; Francesca Valvo
Journal:  Transl Androl Urol       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.